MedTech analysis

United States, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the prevalence and number of hospital discharges in the United States (U.S.) as well as the surgical procedure volumes for selected musculoskeletal diseases/disorders.

January 1, 2013

Drug Delivery: Injection Devices

Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is regarded as one of the most accurate, effective, reliable, and reproducible methods of therapeutic drug and fluid delivery.

December 17, 2019

Neuromodulation: Spinal Cord Stimulation Devices Market

According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.

February 22, 2022

Drug Delivery: Infusion Devices – August 2020

This report provides a discussion of current/forecast markets, competitors, and opportunities in the global infusion drug delivery devices market, including the volumetric, syringe, ambulatory, disposable, implantable, and enteral pumps segments. Geographic regions covered include the US, five major European markets, Japan, and Rest of World markets; the forecast period is from 2019–24.

August 14, 2020

Molecular In Vitro Diagnostic and Screening Tests for Oncology

The market for molecular in vitro diagnostic and screening tests for oncology totaled approximately $1.0bn in 2017, and is projected to expand at a compound annual growth rate (CAGR) of 13.1% during 2017-22, reaching an estimated $1.9bn.

September 13, 2018

European Surgical Procedure Volumes: Breast, general, gynecologic, organ transplant, neurosurgical, ophthalmalogic, and urologic

$3,000.00

This report presents procedure volumes forecasts for some of the most common surgical procedures performed in the five EU countries of France, Germany, Italy, Spain, and the UK (5EU).

December 12, 2017

Drug Delivery: Infusion Devices

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.

March 29, 2018

U.S. Markets for Neurosurgical and Neurointerventional Products

This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market.

Digital Health Technology and Regulatory Overview

This technology report provides an overview of the current landscape for digital health devices and software. This includes a summary of regulation and reimbursement policies and highlights of major product categories.

December 13, 2021

Cardiac Ablation Catheters Market

Cardiac rhythm disorders (also referred to as arrhythmias or dysrhythmias) involve malfunctions of the heart’s electrical system, and may be congenital (present at birth) or acquired (developing after birth).

May 6, 2021

Q4 2017 Meddevicetracker Outlook Report

In this report, we cover catalysts from 9 devices expected to occur in Q4 2017, along with an overview of selected presentations from the upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference. The last page of this report contains an excel sheet of the Large Impact Catalysts expected to occur in Q4 2017.

October 2, 2017

Biomedtracker / Meddevicetracker Q3 2020 Outlook Report

In this report, we cover catalysts from 27 drugs, devices, diagnostics and deals expected to occur in Q3 2020. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

July 1, 2020

U.S. Ophthalmic Surgical Systems Market, April 2014

This report discusses common ophthalmic diseases/disorders, prevalence, estimated U.S. procedure volumes, leading energy-based (laser and phacoemulsification, or “phaco”) ophthalmic surgical systems and their features, and novel technologies. A detailed U.S. market analysis, competitive analysis, and company profiles of selected U.S. competitors are also provided.

April 1, 2014

United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries

December 3, 2012

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products, March 2015

Global Markets for Orthobiologics for the Repair and Regeneration of Bone

The management of musculoskeletal (MSK) disorders is dependent on several factors: geographic location location in the body, cause, patient history, and severity. Treatment options include lifestyle changes, pharmaceutical therapies, and interventional (ie device-based) therapies.

September 30, 2016

Women’s Health: Osteoporosis Diagnostic Products

This report provides analyses of products, markets, and competitors in the global market for osteoporosis diagnostic products. This market, as covered by the scope of this report, includes products that are used to diagnose osteoporosis, including bone densitometry systems and bone remodeling biochemical marker tests.

December 13, 2016

Digital Health: Diabetes Apps and Virtual Coaching

$2,250.00

Smartphone-based digital health technologies are expected to transform the diabetes management market over the next decade by substantially improving diabetes outcomes and reducing healthcare costs. These technologies are engaging and empowering patients, improving glycemic control, and lowering complications. Digital health technologies are defined in this report as: diabetes smartphone apps integrated with blood glucose monitoring devices (both standard blood glucose meters and continuous glucose monitoring systems) and personalized “virtual diabetes coaching” services.

March 10, 2020

Women’s Health: U.S. Markets for Female Urinary Incontinence Therapies

This report focuses on minimally invasive therapy systems and medications designed for the treatment of female UI, including OAB pharmaceutical or drug treatments, injectable urethral bulking agents, and urethral sling systems, of which the OAB drug treatments market contributes the vast majority of revenues.

European Markets for Spinal Motion-Preserving Devices

$4,850.00

This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the European market for nonfusion spinal technologies for the treatment of degenerative disc disease.

General and Pelvic Endoscopic Surgery

This Meddevicetracker report provides an analysis of the market for general and pelvic endoscopic surgery products in the US, five major EU markets, Japan, and the rest of the world. Market segments covered include access devices, access site closure devices, ancillary devices, endoscopes, hand instruments, and insufflation products.

May 16, 2019

U.S. Disease Incidence and Prevalence

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

November 3, 2014

Spain, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Spain.

November 1, 2013

U.S. Markets for Obesity Drugs & Devices

$5,250.00

U.S. Markets for Obesity Drugs & Devices

France, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in France

November 1, 2012

Point of Care Diagnostics

Point of care in vitro diagnostics is being applied to an increasingly wide range of applications in infectious disease, cardiovascular, respiratory, and metabolic disease diagnosis and screening. The market is undergoing rapid expansion, primarily due to the demand for COVID-19 testing; however, other product segments will also contribute to market growth during the forecast period.

June 28, 2021

Arthroscopy Products and Sports Medicine Fixation Implants (2021)

This Meddevicetracker report provides an analysis of the market for arthroscopy products (including visualization systems, fluid management equipment, and manual and powered instruments) and sports medicine/soft tissue fixation implants for the US, five major EU markets, Japan, and the rest of the world.

March 18, 2021

Diabetes Management: Insulin Pumps Market (2019)

This report provides an overview of diabetes, automated insulin pump systems, and a comprehensive market and competitive analysis.

September 30, 2019

Spinal Fusion: Implanted Instrumentation

Sales of implanted instrumentation for spinal fusion procedures totaled approximately $4.4bn in 2019, with sales expected to climb at a CAGR of 2.2% through 2024. Growth in the spinal fusion instrumentation market is being driven by several factors including the prevalence of degenerative disc disease, new surgical techniques and associated instrumentation that have expanded the range of product indications, and the launch of new enabling technology such as diagnostic, nerve monitoring, and navigation systems (including robotic-assisted surgery).

August 20, 2020